Chang A, Sandweiss L, Bose S
Department of Pathology and Laboratory Medicine, University of California-Los Angeles, 10833 Le Conte Avenue, Los Angeles, California 90095-1732, USA.
Gynecol Oncol. 2001 Jan;80(1):37-43. doi: 10.1006/gyno.2000.6013.
The objective of this study was to determine the clinical significance of the presence of benign endometrial cells in the Pap smears of postmenopausal women.
A retrospective analysis of the clinical outcome of 297 postmenopausal women containing benign endometrial cells in their Pap smears was performed. All patients had subsequent endometrial biopsies or routine follow-up for 1-5 years. In addition, Pap smears of 253 of the patients were reviewed with particular reference to the morphology and type of the endometrial cells. Immunohistochemical staining with CD68 was performed in 15 selected cases to determine the origin of the stromal cells.
One hundred thirty-two (44%) women had endometrial biopsies while the remaining 165 (56%) were followed up by routine gynecologic examinations and repeat Pap smears. Endometrial lesions were detected in 14 patients of whom only 3 had significant lesions (2 atypical hyperplasias and 1 adenocarcinoma). Review of the Pap smears revealed benign superficial endometrial stromal cells in most cases (73%). Stromal cells showed CD68 positivity indicating a histiocytic origin. Glandular cells were present in 27%, either alone or in association with stromal cells. Statistical analysis revealed that the presence of endometrial glandular cells in Pap smears was associated with five times the likelihood of significant endometrial disease than found in women with normal Pap smears, although sensitivity and positive predictive value were very low (7.14 and 2.94%, respectively). Superficial endometrial stromal cells were not useful in predicting endometrial pathology.
Significant endometrial lesions were present in 1% of postmenopausal women containing morphologically benign endometrial cells in the Pap smears. In the majority, the endometrial cells were of the superficial stromal type, which were demonstrated immunohistochemically to be histiocytes. The presence of endometrial glandular cells correlated significantly with endometrial pathology. Such an association was not observed in cases with stromal cells only.
本研究的目的是确定绝经后妇女巴氏涂片检查中出现良性子宫内膜细胞的临床意义。
对297例巴氏涂片检查中含有良性子宫内膜细胞的绝经后妇女的临床结局进行回顾性分析。所有患者随后均进行了子宫内膜活检或1至5年的常规随访。此外,对253例患者的巴氏涂片进行了复查,特别参考了子宫内膜细胞的形态和类型。对15例选定病例进行了CD68免疫组化染色,以确定基质细胞的来源。
132例(44%)妇女进行了子宫内膜活检,其余165例(56%)通过常规妇科检查和重复巴氏涂片进行随访。在14例患者中检测到子宫内膜病变,其中只有3例有明显病变(2例不典型增生和1例腺癌)。对巴氏涂片的复查显示,大多数病例(73%)为良性浅表子宫内膜基质细胞。基质细胞显示CD68阳性,表明其起源于组织细胞。腺细胞占27%,单独或与基质细胞同时存在。统计分析显示,巴氏涂片中存在子宫内膜腺细胞的妇女发生明显子宫内膜疾病的可能性是巴氏涂片正常妇女的5倍,尽管敏感性和阳性预测值非常低(分别为7.14%和2.94%)。浅表子宫内膜基质细胞对预测子宫内膜病理情况没有帮助。
在巴氏涂片中有形态学上良性子宫内膜细胞的绝经后妇女中,1%存在明显的子宫内膜病变。在大多数情况下,子宫内膜细胞为浅表基质型,免疫组化显示为组织细胞。子宫内膜腺细胞的存在与子宫内膜病理情况显著相关。仅存在基质细胞的病例未观察到这种关联。